A
ADMA Biologics, Inc.
ADMA · NASDAQ · Healthcare · 2.2B
Closing price
$10.36
+0.29% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
16.8×
Price / net assetsP/B
5.2×
Enterprise value / EBITDAEV/EBITDA
12.4×
Free cash flow yieldFCF yield
1.1%
Return on equityROE
30.8%
Operating margin
37.5%
Net debt / EBITDAbalance-sheet strength
-0.0×
Interest coverage
26.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.